Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels

This study has been completed.
Information provided by (Responsible Party):
Amgen Identifier:
First received: June 10, 2005
Last updated: May 10, 2013
Last verified: May 2013